Sunday, May 03, 2009

2 STINSON Brand Innovation clients to participate in upcoming TIDES® event

TIDES® 2009 is coming May 17-20 at the Red Rock outside of Las Vegas. It will bring together leaders in oligonucleotide and peptide development and manufacturing. The program presents novel, in-depth scientific data to advance the development of promising drug candidates.

The agenda includes comprehensive coverage of drug candidates in development, new strategies for formulation and delivery, and the latest in regulatory updates, quality initiatives, process and analytical development, and manufacturing. This allows attendees the opportunity to benchmark their progress against peers, advance their programs, and meet new collaborators.

Two clients of STINSON Brand Innovation will be among the leading pharmaceutical and biotech companies which are developing peptide and oligo drugs and diagnostics. They will be consulting with important users of their products and services in the exhibit hall.

COVIDIEN -- Covidien peptides are developed with superior manufacturing technologies, meticulous attention to quality, and commitment to research and development. "Through the technological innovations that are essential to our mission, we’re breaking down existing manufacturing barriers to enable new growth and expansion of our marketplace." See more at

EMD BIOSCIENCES -- The brand of NOVABIOCHEM® is industry-leading in the manufacture of innovative reagents for peptide synthesis and combinatorial chemistry, labeled peptides, and custom manufactured products. NOVABIOCHEM supplies products to researchers in pharmaceutical and biotechnology companies, academic institutions, and government laboratories throughout the world. "We are very proud of our multi-brand web site which has been created to provide excellent information tools to reach you - our key customers! Our on-line services, e-commerce, technical support, product listings, search capabilities, new product announcements, as well as future web site enhancements, are designed to further strengthen our commitment to provide the highest quality support to life sciences researchers worldwide. Our goal is to give our customers the edge in an ever more competitive research environment by providing them with the most innovative tools supported by comprehensive technical information." Learn more at

No comments: